Umbilical Cord Mesenchymal Stem Cells: Clinical Trials

31 trials of Umbilical Cord Mesenchymal Stem Cells, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

18 unknown, 7 completed, 3 active not recruiting, 2 recruiting. 26 Phase 2, 24 Phase 1, 1 Early Phase 1, 1 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 226Unknown 15, Completed 6, Active not recruiting 3, Recruiting 2
Phase 124Unknown 14, Completed 6, Active not recruiting 3, Recruiting 1
Early Phase 11Not yet recruiting 1
Phase 31Unknown 1

Follow Umbilical Cord Mesenchymal Stem Cells: new trials by email Literature Review of Umbilical Cord Mesenchymal Stem Cells trials Research Report on Umbilical Cord Mesenchymal Stem Cells

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Safety and Efficacy of Allogeneic Umbilical Cord Mesenchymal Stem Cell Therapy in Diabetic Nephropathy Patients: A Clinical Trial
Umbilical Cord Mesenchymal Stem Cells - Diabetic Nephropathy Type 2
Phase 1 / Phase 2RecruitingPT. Prodia Stem Cell Indonesia102026-07-012026-02-09
Umbilical Cord Mesenchymal Stem Cells as Adjuvant Therapy in Group E COPD Patients
Umbilical Cord Mesenchymal Stem Cells, Normal saline placebo - Chronic Obstructive Pulmonary Disease (COPD)
Phase 2RecruitingRSUP Persahabatan202025-08-082026-02-27
Mesenchymal Stem Cell Transfusion for the Treatment of Refractory Lupus Nephritis
Umbilical cord mesenchymal stem cells, Normal saline - Lupus Nephritis
Early Phase 1Not yet recruitingChinese PLA General Hospital962024-10-012024-07-03
Mesenchymal Stem Cells for Frailty Syndrome
umbilical cord mesenchymal stem cells - Pathologic Processes
Phase 1 / Phase 2Active not recruitingMeribank Biotech Co., Ltd.662024-06-032024-07-15
HUC-MSC for Treatment of High-risk HPV Infection
hUC-MSCs, Saline+albumin - Human Papillomavirus Viruses, Mesenchymal Stem Cells
Phase 1 / Phase 2UnknownShanghai East Hospital602024-03-012024-09-24
UC-MSCs in the Treatment of Severe and Critical COVID-19 Patients
umbilical cord mesenchymal stem cells, paxlovid - Mesenchymal Stem Cell, COVID-19 Pneumonia
Phase 3UnknownShanghai East Hospital602023-01-092023-01-12
Combination of Conditioned Medium and Umbilical Cord-Mesenchymal Stem Cells Therapy for Acute Stroke Infarct
Conditioned Medium, Umbilical Cord Mesenchymal Stem Cells, Neurologic and Neutrophic Drugs - Ischemic Stroke
Phase 1 / Phase 2Active not recruitingPT. Prodia Stem Cell Indonesia152022-05-302026-02-25
Stem Cell and Conditioned Medium for Cerebral Palsy
Umbilical Cord Mesenchymal Stem Cells, Conditioned Medium, Standard Therapy - Cerebral Palsy
Phase 1 / Phase 2Active not recruitingPT. Prodia Stem Cell Indonesia782021-10-132026-02-25
Efficacy and Safety of Expanded UCMSCs On Patients With Moderate to Severe Psoriasis
Umbilical cord mesenchymal stem cells - Mesenchymal Stromal Cells, Psoriasis
Phase 1 / Phase 2UnknownGuangdong Provincial Hospital of Traditional Chinese Medicine52021-08-312021-02-09
Administration of Allogenic UC-MSCs as Adjuvant Therapy for Critically-Ill COVID-19 Patients
Oseltamivir, Azithromycin, Umbilical Cord Mesenchymal Stem Cells - COVID, Pulmonary Infection
Phase 1UnknownUniversitas Indonesia402020-07-012020-07-07
Efficacy and Safety of Umbilical Cord Mesenchymal Stem Cells Transplantation in Patients With Type 2 Diabetes Mellitus
Umbilical Cord Mesenchymal Stem Cells, saline - Type 2 Diabetes, Mesenchymal Stem Cells
Phase 1 / Phase 2UnknownShanghai East Hospital302020-04-102020-06-22
Intrathecal Transplantation of UC-MSC in Patients With Early Stage of Chronic Spinal Cord Injury
Umbilical Cord Mesenchymal Stem Cells, Placebos - Spinal Cord Injuries
Phase 2UnknownThird Affiliated Hospital, Sun Yat-Sen University662019-09-012019-05-01
Intrathecal Transplantation of UC-MSC in Patients With Late Stage of Chronic Spinal Cord Injury
Umbilical Cord Mesenchymal Stem Cells - Spinal Cord Injuries
Phase 2UnknownThird Affiliated Hospital, Sun Yat-Sen University432019-09-012019-05-01
Intrathecal Transplantation of UC-MSC in Patients With Sub-Acute Spinal Cord Injury
Umbilical Cord Mesenchymal Stem Cells, Placebo - Spinal Cord Injury
Phase 2UnknownThird Affiliated Hospital, Sun Yat-Sen University842019-09-012019-05-01
Repeated Subarachnoid Administrations of hUC-MSCs in Treating SCI
human umbilical cord mesenchymal stem cells (hUC-MSCs) - Spinal Cord Injuries
Phase 1 / Phase 2CompletedLimin Rong1022018-03-302020-06-30
UCMSC Transplantation in the Treatment of Cartilage Damage
umbilical cord mesenchymal stem cells, Hyaluronic acid - Cartilage Damage, Degenerative Osteoarthritis
Phase 1 / Phase 2UnknownSouth China Research Center for Stem Cell and Regenerative Medicine202016-06-012016-05-18
Safety and Exploratory Efficacy Study of UCMSCs in Patients With Ischemic Heart Disease (SEESUPIHD)
umbilical cord mesenchymal stem cells - Acute Myocardial Infarction, Myocardial Infarction
Phase 1 / Phase 2UnknownSouth China Research Center for Stem Cell and Regenerative Medicine642016-05-012016-01-28
Umbilical Cord Mesenchymal Stem Cells Infusion for Diabetes Related Vascular Complications
Umbilical Cord Mesenchymal Stem Cells, saline - Peripheral Vascular Disease, Ischemia
Phase 1UnknownJie Shen2402016-01-012017-04-06
Allogeneic Human Umbilical Cord Mesenchymal Stem Cells for a Single Male Patient With Duchenne Muscular Dystrophy (DMD)
Umbilical Cord Mesenchymal Stem Cells - Duchenne's Muscular Dystrophy
Phase 1CompletedAllergy and Asthma Consultants, Wichita, Kansas12014-09-012019-09-16
Allogeneic Umbilical Cord Mesenchymal Stem Cell Therapy for Autism
Umbilical cord mesenchymal stem cells - Autism
Phase 1 / Phase 2CompletedTranslational Biosciences202014-07-012017-10-13

Showing 20 of 31. Sign in to see all of them.

Conditions studied

Spinal Cord Injuries (4)  ·  Cardiomyopathy, Dilated (2)  ·  Diabetes Mellitus, Type 2 (2)  ·  Diabetic Foot (2)  ·  Muscular Dystrophy, Duchenne (2)  ·  Arthritis, Rheumatoid (1)  ·  Autistic Disorder (1)  ·  Cerebral Palsy (1)  ·  Chronic Limb-Threatening Ischemia (1)  ·  Colitis, Ulcerative (1)  ·  Coronary Disease (1)  ·  Diabetes Mellitus (1)  ·  Diabetes Mellitus, Type 1 (1)  ·  Diabetic Nephropathies (1)  ·  Drug-Related Side Effects and Adverse Reactions (1)

Sponsors

Qingdao University (5)  ·  PT. Prodia Stem Cell Indonesia (3)  ·  Shanghai East Hospital (3)  ·  Third Affiliated Hospital, Sun Yat-Sen University (3)  ·  Translational Biosciences (3)  ·  Chinese PLA General Hospital (2)  ·  South China Research Center for Stem Cell and Regenerative Medicine (2)  ·  Acibadem University (1)  ·  Allergy and Asthma Consultants, Wichita, Kansas (1)  ·  Guangdong Provincial Hospital of Traditional Chinese Medicine (1)  ·  Institute of Hematology & Blood Diseases Hospital, China (1)  ·  Jie Shen (1)  ·  Limin Rong (1)  ·  Meribank Biotech Co., Ltd. (1)  ·  RSUP Persahabatan (1)

Countries

China (15)  ·  Indonesia (5)  ·  Panama (3)  ·  Chile (1)  ·  Taiwan (1)  ·  Turkey (Türkiye) (1)  ·  United States (1)

Top investigators

Limin Rong, M.D. (3)  ·  Jorge Paz-Rodriguez, MD (2)  ·  Yangang Wang, MD Phd (2)  ·  Fang Li, M.D,.PH.D. (1)  ·  Gang Zhao, MD (1)  ·  Gerardo Castrellon, MD (1)  ·  Ismail H Dilogo, MD, PhD (1)  ·  Jie Shen (1)  ·  Jorge Bartolucci, Dr. (1)  ·  Maurice HV Strickland, MD (1)  ·  Min Li Rong, M.D. (1)  ·  Nelson Novarro, MD (1)  ·  Pingping Huang, M.D. (1)  ·  Rima Haifa (1)  ·  Xiangmei Chen (1)

Results publications

PMID 28974553, PMID 29523171, PMID 31997819, PMID 35505375